Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Role of Allicin in Combination with Fluoxetine for the Treatment of Major Depressive Disorder in Rodents: Pharmacokinetic and Pharmacodynamic Study

Author(s): Ashish Mishra, Sanjeev Kumar Sahu* and Nilesh Jain

Volume 20, Issue 2, 2024

Published on: 10 July, 2023

Article ID: e160523216966 Pages: 10

DOI: 10.2174/1573407219666230516124135

Price: $65

Abstract

Background: Depression is one of the most common neurological disorders for which only symptomatic treatment is available with synthetic drugs with serious side effects. Allicin [S- (2-propenyl)-2-propene-1-sulfinothioate] is a bioactive component derived from Allium sativum L. (Garlic). It has the property to penetrate the blood-brain barrier, which reveals its neuroprotective property. A synthetic drug named fluoxetine (selective serotonin re-uptake inhibitor) was introduced for the clinical treatment of depression. It is a selective serotonin re-uptake inhibitor that is well absorbed after oral administration.

Aims and Objectives: This study aimed to evaluate the anti-depressant effect of fluoxetine alone and in combination with allicin.

Methods: A pharmacokinetic study of allicin alone as well as in combination with fluoxetine was conducted to evaluate peak concentration, peak concentration time, and area under the curve in blood plasma. Furthermore, the biochemical analysis of neurotrophin levels of brain-derived neurotrophic factor (BDNF), serotonin, and dopamine was also performed to determine the antidepressant activity with synergism effect of allicin and fluoxetine.

Results: The results of a pharmacokinetic study for co-administration of fluoxetine with allicin and enhanced neurotrophins and monoamines levels confirmed their effectiveness against depression. They may also be effective in suicidal risk associated with anti-depressant drugs. Conclusion: A combination of synthetic drugs with herbal compounds may be an alternate and effective therapy to overcome harmful effects.

Graphical Abstract

[1]
James, S. L.; Abate, D.; Abate, K. H.; Abay, S. M.; Abbafati, C.; Abbasi, N.; Murray, C. J. L. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study. The Lancet, 2018, 392(10159), 1789-1858.
[http://dx.doi.org/10.1016/s0140-6736(18)32279-7]
[2]
Trivedi, M.H. How can measurement-based care help improve treatment outcomes for major depressive disorder in primary care? J. Clin. Psychiatry, 2020, 81(2), 26539.
[http://dx.doi.org/10.4088/JCP.UT17042BR2C] [PMID: 32220156]
[3]
Collins, P.Y.; Patel, V.; Joestl, S.S.; March, D.; Insel, T.R.; Daar, A.S.; Bordin, I.A.; Costello, E.J.; Durkin, M.; Fairburn, C.; Glass, R.I.; Hall, W.; Huang, Y.; Hyman, S.E.; Jamison, K.; Kaaya, S.; Kapur, S.; Kleinman, A.; Ogunniyi, A.; Otero-Ojeda, A.; Poo, MM.; Ravindranath, V.; Sahakian, B.J.; Saxena, S.; Singer, P.A.; Stein, D.J.; Anderson, W.; Dhansay, M.A.; Ewart, W.; Phillips, A.; Shurin, S.; Walport, M.; Stein, D.J. Grand challenges in global mental health. Nature, 2011, 475(7354), 27-30.
[http://dx.doi.org/10.1038/475027a] [PMID: 21734685]
[4]
Yang, L.; Zhao, Y.; Wang, Y.; Liu, L.; Zhang, X.; Li, B.; Cui, R. The effects of psychological stress on depression. Curr. Neuropharmacol., 2015, 13(4), 494-504.
[http://dx.doi.org/10.2174/1570159X1304150831150507] [PMID: 26412069]
[5]
Nestler, E.J.; Barrot, M.; DiLeone, R.J.; Eisch, A.J.; Gold, S.J.; Monteggia, L.M. Neurobiology of depression. Neuron, 2002, 34(1), 13-25.
[http://dx.doi.org/10.1016/S0896-6273(02)00653-0] [PMID: 11931738]
[6]
Vahia, V. Diagnostic and statistical manual of mental disorders 5: A quick glance. Indian J. Psychiatry, 2013, 55(3), 220-223.
[http://dx.doi.org/10.4103/0019-5545.117131] [PMID: 24082241]
[7]
Hu, S.; Tucker, L.; Wu, C.; Yang, L. Beneficial effects of exercise on depression and anxiety during the covid-19 pandemic: A narrative review. Front. Psychiatry, 2020, 11, 587557.
[http://dx.doi.org/10.3389/fpsyt.2020.587557] [PMID: 33329133]
[8]
Liu, L.; Liu, C.; Wang, Y.; Wang, P.; Li, Y.; Li, B. Herbal medicine for anxiety, depression and insomnia. Curr. Neuropharmacol., 2015, 13(4), 481-493.
[http://dx.doi.org/10.2174/1570159X1304150831122734] [PMID: 26412068]
[9]
Krishnan, V.; Nestler, E.J. The molecular neurobiology of depression. Nature, 2008, 455(7215), 894-902.
[http://dx.doi.org/10.1038/nature07455] [PMID: 18923511]
[10]
Pandya, M.; Altinay, M.; Malone, D.A., Jr; Anand, A. Where in the brain is depression? Curr. Psychiatry Rep., 2012, 14(6), 634-642.
[http://dx.doi.org/10.1007/s11920-012-0322-7] [PMID: 23055003]
[11]
Chinta, S.J.; Andersen, J.K. Dopaminergic neurons. Int. J. Biochem. Cell Biol., 2005, 37(5), 942-946.
[http://dx.doi.org/10.1016/j.biocel.2004.09.009] [PMID: 15743669]
[12]
Jesulola, E.; Micalos, P.; Baguley, I.J. Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothe-sis model - are we there yet? Behav. Brain Res., 2018, 341, 79-90.
[http://dx.doi.org/10.1016/j.bbr.2017.12.025] [PMID: 29284108]
[13]
Martinowich, K.; Lu, B. Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology, 2008, 33(1), 73-83.
[http://dx.doi.org/10.1038/sj.npp.1301571] [PMID: 17882234]
[14]
Lu, B.; Nagappan, G.; Lu, Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb. Exp. Pharmacol., 2014, 220, 223-250.
[15]
Müller, P.; Duderstadt, Y.; Lessmann, V.; Müller, N.G. Lactate and BDNF: Key mediators of exercise induced neuroplasticity? J. Clin. Med., 2020, 9(4), 1136.
[http://dx.doi.org/10.3390/jcm9041136] [PMID: 32326586]
[16]
Yang, T.; Nie, Z.; Shu, H.; Kuang, Y.; Chen, X.; Cheng, J.; Yu, S.; Liu, H. The role of BDNF on neural plasticity in depression. Front. Cell. Neurosci., 2020, 14, 82.
[http://dx.doi.org/10.3389/fncel.2020.00082] [PMID: 32351365]
[17]
Murawska-Ciałowicz, E.; Wiatr, M.; Ciałowicz, M.; de Assis, G.G.; Borowicz, W.; Rocha-Rodrigues, S.; Paprocka-Borowicz, M.; Marques, A. BDNF impact on biological markers of depression-role of physical exercise and training. Int. J. Environ. Res. Public Health, 2021, 18(14), 7553.
[http://dx.doi.org/10.3390/ijerph18147553] [PMID: 34300001]
[18]
Abdul Shukkoor, M.S.; Baharuldin, M.T.H.B.; Mat, J.A.M.; Mohamad, M.M.A.; Fakurazi, S. Antidepressant-like effect of lipid extract of channa striatus in chronic unpredictable mild stress model of depression in rats. Evid Based Complement Alternat Med., 2016, 2016, 2986090.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy